Shenzhen Core Medical Technology Co.,ltd.

This study tests a new heart pump called Corheart 6 in 50 adults with severe, end-stage heart failure. The pump helps the heart pump blood when it is too weak. The main goal is to see if the pump works safely and keeps patients alive without major problems like disabling stroke o…

This study compares a new heart support device (CorVad) to standard ECMO in 262 high-risk patients with complex coronary artery disease who need angioplasty. The goal is to see if CorVad better maintains heart function and reduces complications during the procedure. Participants …